FY 2018 Results Presentation - Aviva Plc

3y ago
15 Views
3 Downloads
780.12 KB
48 Pages
Last View : 10d ago
Last Download : 3m ago
Upload by : Camille Dion
Transcription

Aviva plcResults 2018

DisclaimerCautionary statements:This should be read in conjunction with the documents distributed by Aviva plc (the “Company” or “Aviva”) through The Regulatory News Service (RNS). This presentation contains, and we maymake other verbal or written “forward-looking statements” with respect to certain of Aviva’s plans and current goals and expectations relating to future financial condition, performance, results,strategic initiatives and objectives. Statements containing the words “believes”, “intends”, “expects”, “projects”, “plans”, “will,” “seeks”, “aims”, “may”, “could”, “outlook”, “likely”, “target”, “goal”,“guidance”, “trends”, “future”, “estimates”, “potential” and “anticipates”, and words of similar meaning, are forward-looking. By their nature, all forward-looking statements involve risk anduncertainty. Accordingly, there are or will be important factors that could cause actual results to differ materially from those indicated in these statements. Aviva believes factors that couldcause actual results to differ materially from those indicated in forward-looking statements in the presentation include, but are not limited to: the impact of ongoing difficult conditions in theglobal financial markets and the economy generally; the impact of simplifying our operating structure and activities; the impact of various local and international political, regulatory andeconomic conditions; market developments and government actions (including those arising from the referendum on UK membership of the European Union); the effect of credit spreadvolatility on the net unrealised value of the investment portfolio; the effect of losses due to defaults by counterparties, including potential sovereign debt defaults or restructurings, on the valueof our investments; changes in interest rates that may cause policyholders to surrender their contracts, reduce the value of our portfolio and impact our asset and liability matching; the impactof changes in short or long term inflation; the impact of changes in equity or property prices on our investment portfolio; fluctuations in currency exchange rates; the effect of market fluctuationson the value of options and guarantees embedded in some of our life insurance products and the value of the assets backing their reserves; the amount of allowances and impairments takenon our investments; the effect of adverse capital and credit market conditions on our ability to meet liquidity needs and our access to capital; changes in, or restrictions on, our ability to initiatecapital management initiatives; changes in or inaccuracy of assumptions in pricing and reserving for insurance business (particularly with regard to mortality and morbidity trends, lapse ratesand policy renewal rates), longevity and endowments; a cyclical downturn of the insurance industry; the impact of natural and man-made catastrophic events on our business activities andresults of operations; our reliance on information and technology and third-party service providers for our operations and systems; the inability of reinsurers to meet obligations or unavailabilityof reinsurance coverage; increased competition in the UK and in other countries where we have significant operations; regulatory approval of extension of use of the Group’s internal model forcalculation of regulatory capital under the European Union’s Solvency II rules; the impact of actual experience differing from estimates used in valuing and amortising deferred acquisition costs(“DAC”) and acquired value of in-force business (“AVIF”); the impact of recognising an impairment of our goodwill or intangibles with indefinite lives; changes in valuation methodologies,estimates and assumptions used in the valuation of investment securities; the effect of legal proceedings and regulatory investigations; the impact of operational risks, including inadequate orfailed internal and external processes, systems and human error or from external events (including cyber attack); risks associated with arrangements with third parties, including joint ventures;our reliance on third-party distribution channels to deliver our products; funding risks associated with our participation in defined benefit staff pension schemes; the failure to attract or retain thenecessary key personnel; the effect of systems errors or regulatory changes on the calculation of unit prices or deduction of charges for our unit-linked products that may require retrospectivecompensation to our customers; the effect of fluctuations in share price as a result of general market conditions or otherwise; the effect of simplifying our operating structure and activities; theeffect of a decline in any of our ratings by rating agencies on our standing among customers, broker-dealers, agents, wholesalers and other distributors of our products and services; changesto our brand and reputation; changes in government regulations or tax laws in jurisdictions where we conduct business, including decreased demand for annuities in the UK due to proposedchanges in UK law; the inability to protect our intellectual property; the effect of undisclosed liabilities, integration issues and other risks associated with our acquisitions; and thetiming/regulatory approval impact, integration risk, and other uncertainties, such as non-realisation of expected benefits or diversion of management attention and other resources, relating toannounced acquisitions and pending disposals and relating to future acquisitions, combinations or disposals within relevant industries; the policies, decisions and actions of government orregulatory authorities in the UK, the EU, the US or elsewhere, including the implementation of key legislation and regulation. For a more detailed description of these risks, uncertainties andother factors, please see ‘Other information – Shareholder Information – Risks relating to our business’ in Aviva’s most recent Annual Report. Aviva undertakes no obligation to update theforward looking statements in this presentation or any other forward-looking statements we may make. Forward-looking statements in this presentation are current only as of the date on whichsuch statements are made.

2018 key financial metricsEPSCapitalOperating EPS58.4p, 7%Solvency II ratio204%Operating profit 3,116m, 2%412Capital generation 3.2bnCashDividendCash remittances 3.1bn, 31%30.0p per share 9%Centre liquidity 1.6bn51.4% pay-out ratio 1.4ppAll footnotes on page 483

Extending our EPS and DPS growth track recordDividend per share: 9%Operating EPS: 7%Moving to a progressive dividend policy 9% 7% 18% 7% 12% 15% 3% 1pFY17FY18FY14All footnotes on page 4820.8pFY1530.0p23.3pFY16FY17FY18

6 out of 8 major markets delivered strong operating profit growth1UKFrance5 2,324m 7%Aviva Investors 150m6(10)% 546mPoland 8%Ireland 100m 190mCanada 7%Singapore 16% 125mAll footnotes on page 48 14% 0% 46mItaly 188m 16%

Operating profit1 mFY17FY18ChangeUK Insurance52,1642,3247%Aviva Investors168150(10)%Canada4646-France (excl. Antarius)5075468%Poland1771907%Italy (excl. Avipop)16218816%Ireland (incl. Friends gic investments(85)(142)(67)%Corporate costs, non insurance & other(150)(224)(49)%Group debt costs5(389)(355)9%FPI11915127%Contribution from disposals*15317(89)%3,0683,1162%Major marketsTotal major marketsOperating profit7*Disposals include Antarius in France, Avipop in Italy and SpainAll footnotes on page 48Operating EPS58.4p 7%Operating EPSafter I&R costs58.4p 12%

UK InsuranceLife core segmentsGeneral Insurance 7%Annuities & Equity Release:779725Net written premiums ( m) 4.8bn PVNBP ( 12%) from strong BPA trading ( 27%) Our largest ever BPA win (M&S: 0.9bn) Inforce profit growth up 7% with stable margin at 68bps4,1934,078 Growth in our preferred channels and productsdespite a softer motor market 8% Commercial from SME & GCS 11% Direct Home 7%Long-term savings:198185 116bn AuA (-2%); 23bn Platform AuA ( 12%)Combined ratio (%) Continued positive net flows of 5.0bn (FY17: 5.6bn) PY releases 2.5pp (FY17: 1.0pp) due tofavourable attritional & large injury claims Stable inforce margin (25bps)-Protection:227226FY17FY1893.9 New business sales down 8%: competitive market withhardening reinsurance rates Lower benefit from benign weather: 0.7ppfavourable to budget vs. 2.0pp in PY 97.0% normalised COR (FY17: 96.9%) Existing business profits up 39%: improved claimsexperience in Group from 2H17 actions 4%Operating profit ( m)Life Other93.8Operating profit ( m) 90m higher profit contribution mainly driven by continuedbenefits from positive longevity developments415400 Underwriting result up 3% as business hasgrown while maintaining margin LTIR5 up 5% from updated investment mixLife Legacy8All footnotes on page 48Stable margin of 41bps; Operating profit down 4% to 318m;Maintaining guidance of c10% p.a. run offFY175FY18

Aviva InvestorsPerformanceOperating profit1 m21% Revenue increased by 4% to 597m (FY17: 577m) Operating profit margin of 25% (FY17: 29%) due to investment inexpanding our Equity, Real Assets & distribution capabilities, andthe absorption of MiFID II costs External clients: 19% of AUM and 31% of revenue (FY17: 21%and 34% respectively) Inflows in US and Canadian fixed income, institutional real assetmandates and insourcing of 2.3bn of Stewardship funds AUM of 331bn (FY17: 351m) due to adverse market and FXmovements, disposals and net outflows of 7bn, primarily frominternal legacy products. AIMS AUM 10.3bn (FY17: 12.6bn) Origination of illiquid assets up 41% to 5.8bn (FY17: 4.1bn) Cash remitted to Group increased by 34m to 92m (FY17: 58m)(10)%FM 32%168150139105FY159FY16FY17FY18All footnotes on page 48

CanadaPerformanceOperating profit1 m26% Continued progress from recovery plan: operating profit stable at 46mdespite a 13m loss in the first half, challenging market conditions andabsorption of RBC GI integration costs within 2018 operating expenses COR 102.4% (FY17: 102.2%) with PY releases vs. strengthening inFY17; weather remained broadly stable year on year with a benign2H18 after significant wind & ice storms in HY18 Commercial COR 97.8% while Personal COR remained 100% Normalised COR 103.4% (FY17: 100.7%); underlying improvementsfrom rates and underwriting discipline were more than offset byelevated attritional claims frequency & severity as well as c 35m higherlarge losses vs. FY17 Approval received for rate increases of 8.6% and 16.8% for Aviva andRBC Ontario motor books respectively from Q1 2019(83)%Target COR 94-96%by 2020269214-FY15FY164646 NWP broadly stable at 2.9bn as price increases offset lower retentionFY17FY18 Remediating actions around pricing, risk selection, distribution & claimscontinue: on track to return COR to targeted 94-96% range by 2020GI10All footnotes on page 48

FrancePerformance*Operating profit1* m8%20%39971328FY1511GI & Health110421104FY16 Life operating profit 7% (excl. FX) despite market volatility andincreased competition in Protection as a result of strong savingssales and sustained cost discipline Continued to shift mix towards UL ahead of market: 37% ofPVNBP vs. 29% market COR stable at 94.5% as underlying improvements & higher PYreleases offset adverse large losses & weather-related claims403 NWP 5% (excl. FX) mainly from growth in commercial lines Successful FRPS implementation: 1st insurer to be granted alicence, further improving capital efficiency and strengtheningretirement and pensions offeringFY17 Strategy to align distribution channels under a single brandprogressing at pace: direct/digital successfully realigned in 2018*All numbers exclude Antarius (disposal completed 1Q17)All footnotes on page 48Life(excl. Antarius)70351Strong distribution footprint, with increased brand recognitionproviding an opportunity to expand our presence with customers5465076% 436FY18

PolandPerformanceOperating profit1 m7%26%1901771%13910FY1512High ROCE multi-line franchise with multi-channel distributionLife Life operating profit 8% (excl. FX) mainly from higher openingassets under management driving increased fee income VNB stable at 58m (FY17: 57m); Maintained high quality mixwith protection and unit-linked sales 80% of total PVNBP COR stable at 87.0% (FY17: 86.7%) with lower NWP fromproduct mix Expense discipline: cost base down 1% (excl. FX) Growth in our distribution partnerships supported by a targetedproduct strategy and retention actions21140815612920 GI170132FY16FY17FY18All footnotes on page 48

ItalyPerformance*Operating profit1* m16%18%(12)%311531301316232Life(excl. Avipop) Net inflows up 57% to 3.6bn (FY17: 2.3bn) from continuedsuccess of capital-light ‘hybrid’ products which contributed 44%of total life sales (FY17: 23%) Life operating profit 14% (excl. FX) mainly driven by stronggrowth in new business volumes of hybrid product; VNB 36%in local currency to 222m (FY17: 162m) COR improved to 95.1% (FY17: 98.1%) from remediating motorbook; NWP down 7% (excl. FX) Continued focus on expanding and diversifying distributioncapability: non banks channels accounted for 40% of lifeinsurance sales in 2018 Completed sale of Avipop JV to Banco BPM for 265m;retained proceeds locally to fund growth and address localeconomic volatility2626FY15Multi-line business with major bancassurance partnerships andgrowth through FA channelGI188184156 FY16156136FY17*All numbers exclude Avipop (disposal completed 1Q18)All footnotes on page 48FY18

IrelandPerformance*Operating profit1* m16%10018%8640% Largest multi-line insurer with a leading brand and 15% marketshare in both Life and GI Friends First acquisition completed in June & already accretiveto operating profit; integration progressing at pace, on track todeliver targeted benefits over 2019 and beyond COR 91.5% (FY17: 91.4%) as improved underlying performanceand more benign weather were mainly offset by higher largelosses NWP 430m (FY17: 436m) with focus remaining on pricingdiscipline in a softening motor market Life operating profit up 11m mainly driven by Friends Firstcontribution, longevity releases and asset mix optimisation onannuity bookGILife7356525341284424FY151432FY1633FY17*2018 numbers include Friends First (acquired 2H18)All footnotes on page 48FY18*

SingaporePerformanceOperating profit1 m14%10%14% Leading life & health franchise and market leaders in FA space Distribution in financial advisory subsidiaries continues to growwith 1,540 advisors (FY17: 1,266) including Aviva FinancialAdvisors, which is now at 816 (FY17: 673) Continued growth with operating profit up 16% (excl. FX) drivenby growth in the financial advisory channel in Life VNB up 25% (excl. FX) to 152m (FY17: 123m) with strongsales from FA channel and improved mix towards protection General Insurance & Health impacted by increased claimsfrequency where management is implementing remedial actionsto improve the business Cash dividend resumed with payment of 6mLife125GI & 16)FY18All footnotes on page 48

Operating profit1 mFY17FY18ChangeUK Insurance52,1642,3247%Aviva Investors168150(10)%Canada4646-France (excl. Antarius)5075468%Poland1771907%Italy (excl. Avipop)16218816%Ireland (incl. Friends gic investments(85)(142)(67)%Corporate costs, non insurance & other(150)(224)(49)%Group debt costs5(389)(355)9%FPI11915127%Contribution from disposals*15317(89)%3,0683,1162%Major marketsTotal major marketsOperating profit16*Disposals include Antarius in France, Avipop in Italy and SpainAll footnotes on page 48Operating EPS58.4p 7%Operating EPSafter I&R costs58.4p 12%

Operating EPS progression2018 operating EPS growth58.4p54.8pFY17operating EPS17c(2)% ges & prioryear developmentWeather,change spend& otherUnderlyinggrowthOperatingtax2017-18capital returnsAll footnotes on page 48FY18operating EPS

Net asset valueOpening NAV per shareat 1 January 20187Basic EPS423pOgden60pOperating profit(29)pDividendsOgdenLower share count12pMarket movements(15)pPension movement(6)p15.3pFY15FY16FY18Integration & restructuring costs(9)pAVIF amortisation 379m2pDisposals 212mOther18FY174pOgden8Closing NAV per shareat 31 December 201838.2p23.1p(15)pShare buyback35.0p(3)pFY15424pAll footnotes on page 48FY16 141mFY17 0mFY18

CapitalSII cover ratioSII working range: 160-180%2Shareholder basisRevised from previous 150-180% range set early 2016204%Reflects stable risk appetite on stronger capital position198%Consistent with AA credit rating189%180%180%160%FY1519FY16FY17FY18All footnotes on page 48 0.6bn 0.9bn2018 share buy-backCumulative 2017-18share buy-backs 0.9bn 1.4bn2018 redemptions: 6.875%T2 and 7.875% RT1 notesCumulative 2017-18 nethybrid debt redemptions

Capital resilient to stressFY18 SII cover ratio2204%Interest rates 25bps207%Interest rates -25bps200%Interest rates -50bps194%Corporate spreads -50bps206%Corporate spreads 50bps200%Corporate spreads 100bps196%Equities -25%199%Longevity shock: 5% fall in mortality rates (annuities)193%Rating downgrade on annuity portfolio bonds200%10% increase in maintenance & investment expenses196%10% increase in lapse rates201%5% increase in gross loss ratios201%160%20 Above top end of 160-180% revised working rangeacross all sensitivities Extensive planning and scenario testing for Brexit;remain resilient and have taken some pre-emptiveactions including hedging and increasing Brexitreserves by c 100m to c 400m Prudent risk management with active reinsurance andhedging strategies: further equity/equity volatilityhedges bought in 2018 Efficient asset allocation that manages risk whilstseeking to boost return on capital180%All footnotes on page 48

Investment portfolio qualityIFRS shareholder assetsCorporate debtFY18AAA AAA9% 11%36%BBB BBB NR13% 24bn30%56% rated A 84bn86% BBB 80bnFY11* 3% 12%39%4% 13% 39bn29%Government debt16%28%Corporate bonds& other debtLoans - mortgagesAAAAAA24%63%5%Loans - otherOther investments54%33%Government debtFY1892% rated AFY11*24%7%5%FY117%FY18incl. US*21*FY11 as reported, incl. US business disposed of in 201218%UK Commercial: 7bn25%1%62%MortgagesLow LTVs, high LICs102%Equity release: 10bn2.8x55%28%FY11FY18FY11LIC 22bn 13bn15%1.3x**non-securitised only5%27%**LTVFY18**

Capital generation 2.7bn spent on dividend payment, share buyback and debt repayments in 2018 Underlying OCG – lower mainly reflecting:‐ c 0.1bn higher digital & investment spend as we continue to manage costs in linewith temporarily higher longevity benefits included in ‘Other’ OCGOperating capitalgeneration (‘OCG’)Underlying OCG 3.2bn‐ c 0.1bn impacts from disposals in Italy, Spain and FranceActions include ( bn):UKL longevity releasesUKI hedging/modellingDVA at Group levelFrance FRPS benefit 1.5bn0.60.40.60.2 0.2bn (0.5)bn198%204% (1.1)bn 1.7bn (1.5)bn 2.0bn (1.2)bn 0.2bn 12.2bn31-Dec-1722 12.0bnBU underlyinggenerationDebt ¢re costsOther capitalactionsOgden8Market, FXand otherAll footnotes on page 482018 capitalreturnsDividendM&A31-Dec-18

Cash 3.1bn cash remitted in 2018, 31% mFY169FY171,8002,549UKI underlying9371,3001,299Friends Life 8107AsiaAviva Investors & OtherCash remittances 7.3bnFY16-18 cumulative cash remittances,of which 2.0bn of UKI special 750Other special23FY181,187UKI 7.9bn FY16-18 cash remitted to Centrevs. 8bn target1,8052,398 0.6bnIncl. Spanish sale proceeds remitted to Centre Total remitted, broadly in line with target 7.9bn3,137Excludes: ‐ Avipop proceeds: 0.2bn retained locallygiven high market volatility environment‐ FPI: completion for 0.3bn delayedAll footnotes on page 48

Financial leverageSII debt leverage* 1.5bn debt reductionplanned by 2021-22Plan to repay without refinancing at least 1.5bn of deb

Aviva plc Results 2018. . This should be read in conjunction with the documents distributed by Aviva plc (the “Company”or “Aviva”)through The Regulatory News Service (RNS). This presentation contains, and we may make other verbal or written “forward-looking statements”with respect to certain of Aviva’splans and current goals and .

Related Documents:

Jacks Lane Energy Limited Aviva Corporation HILLSWOOD MANAGEMENT LIMITED Aviva Corporation AIEREF Holding 2 Aviva Corporation Kroknet S. a. r. l. Aviva Corporation Aviva Group Holdings Limited Aviva Corporation AIEREF Renewable Energy s.r.o. Aviva Corporation Lancashire and Yorkshire Rev

Aviva plc . Results . 2017 . Disclaimer . Cautionary statements: This should be read in conjunction with the documents distributed by Aviva plc (the “Company” or “Aviva”) through The Regulatory News Service (RNS). This presentation contains, and we may . Aviva plc - Results presentation FY 2017 .

The Accu-Chek Aviva Nano System Your new Accu-Chek Aviva Nano Meter is for quantitative blood glucose testing using Accu-Chek Aviva Strips. Suitable for self-testing. The Accu-Chek Aviva Nano Meter may be used by patients who test their own blood glucose as well as by healthcare pr

The ACCU-CHEK Aviva System Your new ACCU-CHEK Aviva meter and accessories work together to measure the amount of sugar (glucose) in your blood to help you and your doctor control your diabetes. The system includes: 2 ACCU-CHEK Aviva meter with battery ACCU-CHEK Aviva test strips and code key (may be sold separately)

2013 Results Presentation. . Actual results may vary materially from those targeted, expected or projected due to several factors. Potential risks and . JV Agreement signed with Aviva plc to form Astra Aviva Life. Financial Performance. Consolidated income statement 9

The Strategic report is only part of the Annual report and accounts 2019. The Strategic report was approved by the Board on 4 March 2020 and signed on its behalf by Maurice Tulloch, Chief Executive Officer. More information about Aviva can be found at www.aviva.com Non-Financial Information Statement

The Accu-Chek Nano (not Aviva or Performa) and Accu-Chek Aviva Plus glucose systems are available within the United States ONLY, and use test strips branded as Accu-Chek Smartview and Accu-Chek Aviva Plus, respectively. These systems use the Mut Q-GDH (compatible)

AngularJS is an extensible and exciting new JavaScript MVC framework developed by Google for building well-designed, structured and interactive single-page applications (SPA). It lays strong emphasis on Testing and Development best practices such as templating and declarative bi-directional data binding. This cheat sheet co-authored by Ravi Kiran and Suprotim Agarwal, aims at providing a quick .